Unique overlap in the prerequisites for thrombin inhibition and oral bioavailability resulting in potent oral antithrombotics.
Adang AE, de Man AP, Vogel GM, Grootenhuis PD, Smit MJ, Peters CA, Visser A, Rewinkel JB, van Dinther T, Lucas H, Kelder J, van Aelst S, Meuleman DG, van Boeckel CA.
Adang AE, et al. Among authors: kelder j.
J Med Chem. 2002 Sep 26;45(20):4419-32. doi: 10.1021/jm011110z.
J Med Chem. 2002.
PMID: 12238922